+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023

  • ID: 4603521
  • Report
  • Region: Global
  • 134 Pages
  • Markets and Markets
1 of 5
The Global Autoinjectors Market is Projected to Reach USD 85.31 Billion by 2023 From USD 28.91 Billion in 2018 at a CAGR of 24.2% During the Forecast Period

FEATURED COMPANIES

  • Abbvie
  • AstraZeneca
  • Biogen
  • Haselmeier
  • Merck
  • Novartis
  • MORE

The autoinjectors market is projected to grow at a CAGR of 24.2% during the forecast period.

The global autoinjectors market is expected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period. Growing prevalence of targeted therapies, rising incidence of anaphylaxis, increasing number of regulatory approvals, and technological advancements in autoinjector devices are expected to drive the growth of the autoinjectors market. However, the preference for alternative routes of drug delivery such as oral diabetic agents and epinephrine nasal sprays is expected to restrain the growth of this market to a certain extent.

By therapy, the rheumatoid arthritis segment is expected to grow at the highest CAGR during the study period.

Based on therapy, the global autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies. The rheumatoid arthritis segment is expected to grow at the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the high prevalence of rheumatoid arthritis across the globe.

By type, the disposable autoinjectors segment is expected to grow at the highest rate during the forecast period (2018–2023).

Based on type, the market is segmented into disposable and reusable autoinjectors. The disposable autoinjectors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the benefits these autoinjectors offer, such as portability, ease of use, and a lower possibility of infection.

The North American autoinjectors market is expected to grow at the highest CAGR during the forecast period.

North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of anaphylaxis, autoimmune diseases, and chronic diseases in the US and Canada; favorable reimbursement scenario; and increasing number of awareness programs in the region.

Research Coverage:
The report analyzes the autoinjectors market and aims at estimating the market size and future growth potential of this market based on various segments such as therapy, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share.

Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the autoinjectors market. The report analyzes the market based on therapy, type, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the autoinjectors market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various autoinjectors across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the autoinjectors market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbvie
  • AstraZeneca
  • Biogen
  • Haselmeier
  • Merck
  • Novartis
  • MORE

1 Introduction

1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
   1.3.1 Years Considered for the Study
   1.3.2 Markets Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology

2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
   2.2.1 Secondary Research
   2.2.2 Primary Research
        2.2.2.1 Key Data From Primary Sources
        2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights

4.1 Autoinjectors Market Overview
4.2 Autoinjectors Market, By Type, 2018 vs 2023
4.3 Geographic Analysis: Autoinjectors Market, By Therapy
4.4 Autoinjectors Market, By End User, 2018 vs 2023
4.5 Geographic Snapshot: Autoinjectors Market

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
   5.2.1 Drivers
        5.2.1.1 Growing Prevalence of Targeted Therapies
        5.2.1.2 Rising Incidence of Anaphylaxis
        5.2.1.3 Increasing Number of Regulatory Approvals
        5.2.1.4 Availability of Generic Versions of Autoinjectors
        5.2.1.5 Favorable Reimbursements and Government Support
        5.2.1.6 Technological Advancements and Design Development
   5.2.2 Restraints
        5.2.2.1 Preference for Alternative Drug Delivery Modes
               5.2.2.1.1 Oral Diabetic Agents and Oral Insulin
               5.2.2.1.2 Epinephrine Nasal Sprays
   5.2.3 Opportunities
        5.2.3.1 Patent Expiry of Biologics to Drive the Demand for Biosimilars
   5.2.4 Challenges
        5.2.4.1 Development of Autoinjectors for Multiple Drug Viscosities
        5.2.4.2 Lack of Proper Training for Using Autoinjectors

6 Autoinjectors Market, By Therapy

6.1 Introduction
6.2 Rheumatoid Arthritis
6.3 Multiple Sclerosis
6.4 Diabetes
6.5 Anaphylaxis
6.6 Other Therapies

7 Autoinjectors Market, By Type

7.1 Introduction
7.2 Disposable Autoinjectors
7.3 Reusable Autoinjectors

8 Autoinjectors Market, By End User

8.1 Introduction
8.2 Home Care Settings
8.3 Hospitals & Clinics

9 Autoinjectors Market, By Region

9.1 Introduction
9.2 North America
   9.2.1 US
   9.2.2 Canada
9.3 Europe
   9.3.1 Germany
   9.3.2 UK
   9.3.3 France
   9.3.4 Rest of Europe
9.4 Asia Pacific
   9.4.1 Japan
   9.4.2 China
   9.4.3 India
   9.4.4 RoAPAC
9.5 Rest of the World

10 Competitive Landscape

10.1 Overview
10.2 Market Share Analysis
10.3 Market Ranking of OEM Companies
10.4 Market Share Analysis, By Therapeutic Area
     10.4.1 Rheumatoid Arthritis
     10.4.2 Multiple Sclerosis
     10.4.3 Diabetes
     10.4.4 Anaphylaxis
10.5 Competitive Scenario
     10.5.1 Product Launches and Approvals
     10.5.2 Expansions
     10.5.3 Agreements, Collaborations, and Partnerships

11 Company Profiles

11.1 Abbvie
11.2 Mylan
11.3 ELI Lilly
11.4 Ypsomed
11.5 Amgen
11.6 Becton, Dickinson and Company
11.7 Owen Mumford
11.8 Consort Medical
11.9 Haselmeier
11.10 Shl Group (Scandinavian Health Limited)
11.11 Johnson & Johnson (J&J)
11.12 Teva
11.13 Antares Pharma

12 Appendix

List of Tables

Table 1 Recent Approvals of Autoinjector Devices Across the Globe
Table 2 Patent Expiry of Key Biologics
Table 3 Autoinjectors Market, By Therapy, 2016–2023 (USD Billion)
Table 4 Autoinjectors Market for Rheumatoid Arthritis, By Country, 2016–2023 (USD Billion)
Table 5 Autoinjectors Market for Multiple Sclerosis, By Country, 2016–2023 (USD Billion)
Table 6 Autoinjectors Market for Diabetes, By Country, 2016–2023 (USD Million)
Table 7 Autoinjectors Market for Anaphylaxis, By Country, 2016–2023 (USD Million)
Table 8 Autoinjectors Market for Other Therapies, By Country, 2016–2023 (USD Million)
Table 9 Comparison of Disposable & Reusable Autoinjectors
Table 10 Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 11 Disposable Autoinjectors Market, By Country, 2016–2023 (USD Billion)
Table 12 Reusable Autoinjectors Market, By Country, 2016–2023 (USD Million)
Table 13 Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 14 Autoinjectors Market for Home Care Settings, By Country, 2016–2023 (USD Billion)
Table 15 Autoinjectors Market for Hospitals & Clinics, By Country, 2016–2023 (USD Million)
Table 16 Autoinjectors Market, By Region, 2016–2023 (USD Billion)
Table 17 North America: Autoinjectors Market, By Country, 2016–2023 (USD Billion)
Table 18 North America: Autoinjectors Market, By Therapy, 2016–2023 (USD Billion)
Table 19 North America: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 20 North America: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 21 Autoinjectors Approved By the Fda, 2015–2018
Table 22 US: Autoinjectors Market, By Therapy, 2016–2023 (USD Billion)
Table 23 US: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 24 US: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 25 Canada: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 26 Canada: Autoinjectors Market, By Type, 2016–2023 (USD Million)
Table 27 Canada: Autoinjectors Market, By End User, 2016–2023 (USD Million)
Table 28 Product Approvals in Europe, 2015–2018
Table 29 Europe: Autoinjectors Market, By Country, 2016–2023 (USD Billion)
Table 30 Europe: Autoinjectors Market, By Therapy, 2016–2023 (USD Billion)
Table 31 Europe: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 32 Europe: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 33 Germany: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 34 Germany: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 35 Germany: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 36 UK: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 37 UK: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 38 UK: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 39 France: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 40 France: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 41 France: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 42 RoE: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 43 RoE: Autoinjectors Market, By Type, 2016–2023 (USD Million)
Table 44 RoE: Autoinjectors Market, By End User, 2016–2023 (USD Million)
Table 45 Asia Pacific: Autoinjectors Market, By Country, 2016–2023 (USD Billion)
Table 46 Asia Pacific: Autoinjectors Market, By Therapy, 2016–2023 (USD Billion)
Table 47 Asia Pacific: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 48 Asia Pacific: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 49 Japan: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 50 Japan: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 51 Japan: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 52 China: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 53 China: Autoinjectors Market, By Type, 2016–2023 (USD Million)
Table 54 China: Autoinjectors Market, By End User, 2016–2023 (USD Million)
Table 55 India: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 56 India: Autoinjectors Market, By Type, 2016–2023 (USD Million)
Table 57 India: Autoinjectors Market, By End User, 2016–2023 (USD Million)
Table 58 RoAPAC: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 59 RoAPAC: Autoinjectors Market, By Type, 2016–2023 (USD Million)
Table 60 RoAPAC: Autoinjectors Market, By End User, 2016–2023 (USD Million)
Table 61 RoW: Autoinjectors Market, By Therapy, 2016–2023 (USD Million)
Table 62 RoW: Autoinjectors Market, By Type, 2016–2023 (USD Billion)
Table 63 RoW: Autoinjectors Market, By End User, 2016–2023 (USD Billion)
Table 64 Product Launches and Approvals
Table 65 Expansions
Table 66 Agreements, Collaborations, and Partnerships

List of Figures

Figure 1 Autoinjectors Market: Research Methodology Steps
Figure 2 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Rheumatoid Arthritis Therapy Segment to Dominate the Autoinjectors Market in 2018
Figure 8 Disposable Autoinjectors to Account for the Largest Share of the Autoinjectors Market in 2018
Figure 9 Home Care Settings to Dominate the Autoinjectors Market During the Forecast Period
Figure 10 North America to Witness the Highest Market Growth During the Forecast Period
Figure 11 Growing Prevalence of Targeted Therapies and Increasing Number of Regulatory Approvals are Driving Market Growth
Figure 12 Disposable Autoinjectors to Dominate the Market in 2018
Figure 13 Rheumatoid Arthritis Therapy Segment to Command the Largest Share of the Autoinjectors Market in 2018
Figure 14 Home Care Settings to Account for the Largest Market Share in 2018
Figure 15 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 16 Autoinjectors Market: Drivers, Restraints, Opportunities, & Challenges
Figure 17 Autoinjectors Market, By Therapy, 2018 vs 2023 (USD Billion)
Figure 18 Autoinjectors Market, By Type, 2018 vs 2023 (USD Billion)
Figure 19 Autoinjectors Market, By End User, 2018 vs 2023 (USD Billion)
Figure 20 North America to Command the Largest Market Share in 2018
Figure 21 North America: Autoinjectors Market Snapshot
Figure 22 Europe: Autoinjectors Market Snapshot
Figure 23 Asia Pacific: Autoinjectors Market Snapshot
Figure 24 RoW: Autoinjectors Market Snapshot
Figure 25 Market Ranking of OEM Companies
Figure 26 Strategies Adopted By Market Players (2014–2018)
Figure 27 Abbvie: Company Snapshot (2017)
Figure 28 Mylan: Company Snapshot (2017)
Figure 29 ELI Lilly: Company Snapshot (2017)
Figure 30 Ypsomed: Company Snapshot (2017)
Figure 31 Amgen: Company Snapshot (2017)
Figure 32 BD: Company Snapshot (2017)
Figure 33 Consort Medical: Company Snapshot (2017)
Figure 34 Johnson & Johnson: Company Snapshot (2017)
Figure 35 Teva: Company Snapshot (2017)
Figure 36 Antares Pharma: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Abbvie
  • Amgen
  • Teva
  • Biogen
  • Eli Lilly
  • Mylan
  • Merck
  • Ypsomed
  • AstraZeneca
  • J&J
  • Becton Dickinson and Company
  • Owen Mumford
  • Novartis
  • Bayer
  • Haselmeier
Note: Product cover images may vary from those shown
Adroll
adroll